FindTrial
Sign In

The Proper Timing of Phase II Revision in Treating Periprosthetic Knee Infection: Reliable Indicators and Risk Factors

The Proper Timing of Phase II Revision in Treating Periprosthetic Knee Infection: Reliable Indicators and Risk Factors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014991
Enrollment
Unknown
Registered
2018-02-27
Start date
2010-01-01
Completion date
Unknown
Last updated
2018-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periprosthetic Knee Infection

Interventions

Case series:antibiotic therapy

Sponsors

Department of Orthopaedics, Chinese People's Liberation Army General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
36 Years to 78 Years

Inclusion criteria

Inclusion criteria: 1. persistent prosthesis periprosthetic knee joint pain, infection in 3 weeks; 2. diagnosed as periprosthetic knee joint infection by imageological examination; 3. all patients received two-stage revision with articulated antibiotic-loaded cement spacer implantation.

Exclusion criteria

Exclusion criteria: 1. negative culture results, as they were hard to diagnose as PJI even with the MSIS criteria; 2. infectious diseases by other pathogens; 3. bone tumor and serious heart disease, hepatic and renal dysfunction.

Design outcomes

Primary

MeasureTime frame
Spacer Detention Time;Antibiotic treatment time;—

Countries

China

Contacts

Public ContactJiying Chen

Chinese People's Liberation Army General Hospital

hy76yuy@163.com+86 14763482294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026